Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/2000
12/14/2000CA2376506A1 Neuromedin b and somatostatin receptor agonists
12/14/2000CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000CA2376078A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2376012A1 Formulations containing cranberry fruit, dl-methionine, and chinese herbs
12/14/2000CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000CA2375485A1 Method for multiplying stem cells
12/14/2000CA2374558A1 Phospholipid transfer protein
12/13/2000EP1058680A1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
12/13/2000CN1276782A 2-aminotetralines, process for their preparation, and pharmaceutical compositions, for prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
12/13/2000CN1276724A Eprosartan arginyl charge-neutralization-complex and process for its production and formulation
12/13/2000CN1276721A Use of 6,7-substd. 2-aminotetralines suitable for preparing pharmaceutical composition for therapeutic treatment of inflammatory and/or autoimmune pathologies
12/13/2000CN1276227A Process for preparing Chinese medicine preparation of treating pyelonephritis
12/13/2000CN1276211A Use of non-peptides NK3-antagonist
12/12/2000US6159998 Administered as vasodilators, analgesics, anesthetics, sedatives, and anitspasmodic agents
12/12/2000US6159716 Amino acid sequence of serine/threonine kinase; antiulcer/ anticarcinogenic/antiarthritic agents; treatment of parkinson's/huntigton's diseases, tourette's syndrome, eating disorders, osteoporosis, allergies; diagnosis of disease
12/07/2000WO2000073450A2 Cytoskeleton-associated proteins
12/07/2000WO2000073443A1 Lipid metabolism transcription factor
12/07/2000WO2000073327A1 Chemokine receptor ccr3 antagonists
12/07/2000WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation
12/07/2000WO2000073276A2 Carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists
12/07/2000WO2000072863A2 Uses of h-trek-1 polypeptides and polynucleotides encoding them
12/07/2000WO2000072855A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
12/07/2000WO2000072845A1 Il-8 receptor antagonists
12/07/2000WO2000072840A1 Il-8 receptor antagonists
12/07/2000WO2000072701A1 Method and composition for masking mineral taste
12/07/2000WO2000046224A3 Tricyclic pyridine n-oxides vasopressin agonists
12/07/2000DE19924892A1 Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten New carboxylic acid derivatives with aryl-substituted nitrogen heterocycles, their preparation and use as endothelin receptor antagonists
12/07/2000DE19919585A1 Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen Use of Phyllanthus for the treatment of oxidative stress and other symptoms
12/07/2000CA2375855A1 Modulation of gene expression in gastrointestinal inflammation
12/07/2000CA2375683A1 Il-8 receptor antagonists
12/07/2000CA2375666A1 Novel carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists
12/07/2000CA2374376A1 Lipid metabolism transcription factor
12/07/2000CA2374295A1 Il-8 receptor antagonists
12/07/2000CA2374222A1 Cytoskeleton-associated proteins
12/07/2000CA2374119A1 Method and composition for masking mineral taste
12/07/2000CA2372249A1 Chemokine receptor ccr3 antagonists
12/06/2000EP1056754A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
12/06/2000EP1056731A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone
12/06/2000EP1056730A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone
12/06/2000EP1056729A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia
12/06/2000EP1056720A1 Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia
12/06/2000EP1056461A1 Method and means for treating glomerulonephritis
12/06/2000EP1056455A1 Epimorphian compound and its use
12/06/2000EP1056451A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
12/06/2000EP1056449A2 20-hete antagonists and agonists
12/06/2000EP1056413A1 Injectable implants for tissue augmentation and restoration
12/06/2000EP1024701A4 Methods and compositions for the treatment of autoimmune disease using heat shock proteins
12/06/2000CN1275981A Novel pharmaceutically active compounds, their preparation and use as ECE-inhibitors
12/06/2000CN1275911A Method of preventing or treating estrogen-dependent diseases and disorders
12/06/2000CN1059210C Process for preparation of 6-heterocyclic-4-amino-1,3,4,5-tetrahydrbenz [cd] indoles and acid additive salt used as medicine
12/05/2000US6156894 Process for manufacturing α.sub. 1L-adrenoceptor antagonists
12/05/2000US6156780 Treatment of fecal incontinence
12/05/2000US6156752 Optically active 1,4-dihydropyridine compounds as bradykinin antagonists
12/05/2000US6156523 Serine/threonine protein kinases
12/05/2000US6156518 Methods of using DNA encoding human alpha 1 adrenergic receptors
12/05/2000US6156332 Method and composition for masking mineral taste
11/2000
11/30/2000WO2000071716A2 Vascular endothelial growth factor dimers
11/30/2000WO2000071706A1 ANTISENSE TO c-myc FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
11/30/2000WO2000071560A1 Methods of modulating activity of prokaryotic ribosomes
11/30/2000WO2000071549A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000WO2000071548A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
11/30/2000WO2000071537A1 New pharmaceutically active compounds
11/30/2000WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071140A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000WO2000071107A2 New pharmaceutical combinations for nos inhibitors
11/30/2000WO2000047611A3 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
11/30/2000WO2000043413A3 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
11/30/2000WO2000042172A3 Human homologues of proteins regulated by circadian rhythms
11/30/2000WO2000029846A3 COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-α MEDIATED PATHWAY
11/30/2000WO2000024391A3 Conductance of improperly folded proteins through the secretory pathway
11/30/2000CA2381441A1 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000CA2374926A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000CA2374915A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374668A1 New pharmaceutical combinations for nos inhibitors
11/30/2000CA2374499A1 Antisense to c-myc for treatment of polycystic kidney disease
11/30/2000CA2374050A1 Vascular endothelial growth factor dimers
11/30/2000CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds
11/30/2000CA2372743A1 New pharmaceutically active compounds
11/29/2000EP1055665A1 3-(3-Hydroxyphenyl)-3-amino-propionamide derivatives
11/29/2000EP1055426A1 Dysuria remedies
11/29/2000EP1054995A1 GABAB-R2a, A 7TM RECEPTOR
11/29/2000EP1054981A2 Prostate-associated serine protease
11/29/2000EP1054904A1 Mucilage, a g-protein-coupled receptor
11/29/2000EP1054900A1 Therapeutic uses of keratinocyte growth factor-2
11/29/2000EP1054887A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
11/29/2000EP1054886A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
11/29/2000EP1054869A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
11/29/2000EP1054868A1 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000EP1054680A1 Composition and method for the treatment of bladder cancer
11/29/2000EP1054594A1 Inotropic and diuretic effects of exendin and glp-1
11/29/2000CN1275123A Prostaglandin agonists and their use to treat bone disorders
11/29/2000CN1275080A Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus
11/29/2000CN1058964C Branched-amino-sbustituted thiazoles, process for their preparation and the pharmaceutical compositions which contain them
11/29/2000CN1058902C Medical liquid for invigorating kidney Yang
11/28/2000US6153739 Polynucleotides encoding human uridine diphosphate galactose-4-epimerase
1 ... 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 ... 562